Etiology and recurrence risk in Rubinstein-Taybi syndrome

Am J Med Genet Suppl. 1990;6:56-64. doi: 10.1002/ajmg.1320370610.

Abstract

Epidemiologic data on 45 patients with Rubinstein-Taybi syndrome from the Netherlands and 50 patients from the USA are compared with data from 407 patients reported in the literature. The 502 probands had a total of 708 sibs, including one probable recurrence. In 12 of 13 proven or possible monozygotic twins both children were affected. Two patients have reproduced with one affected and 2 normal offspring. The empiric recurrence risk figure for sibs is 0.1%. The recurrence risk for offspring of affected individuals could be as high as 50%. The cause of the syndrome remains unknown. There were no clues for autosomal recessive or X-linked inheritance, nor for a teratogenic cause. No consistent chromosome anomaly was found. An autosomal dominant mutation, either as submicroscopic chromosome deletion or duplication, or a point mutation seems the most likely explanation.

Publication types

  • Review

MeSH terms

  • Abnormalities, Multiple / etiology*
  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Chromosome Aberrations
  • Diseases in Twins / epidemiology
  • Diseases in Twins / etiology
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Netherlands / epidemiology
  • Rubinstein-Taybi Syndrome / epidemiology
  • Rubinstein-Taybi Syndrome / etiology*
  • Rubinstein-Taybi Syndrome / genetics
  • Teratogens / toxicity
  • United States / epidemiology

Substances

  • Teratogens